NCT06069505View on ClinicalTrials.gov

Detection of Azole Resistance Inducing Mutations on DNA Extracted Directly From Serum or Plasma of Immunocompromised Patients With an Invasive Aspergillus Infection Azole Resistance PCR Optimalization-study

RecruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions

Invasive Aspergillosis

Interventions

DIAGNOSTIC_TEST

Aspergillus PCR

Aspergillus PCR will be performed on different volumes of serum and plasma of patients with hematological malignancies with suspicion for invasive fungal infection.

Trial Locations (1)

3000 CA

RECRUITING

Erasmus Medical Center (EMC), Rotterdam

All Listed Sponsors

lead

Bart Rijnders

OTHER